secwatch.observer — SEC 8-K summary
======================================

Issuer:     FATE THERAPEUTICS INC (FATE)
CIK:        0001434316
Form:       8-K
Filed at:   2023-09-01T23:59:59+00:00
Accession:  0001193125-23-227749
Event type: litigation
Sentiment:  negative
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Fate Therapeutics loses summary judgment in patent case against Shoreline; plans appeal
--------------------------------------------------------------------------------

- Court granted Shoreline's summary judgment of non-infringement on Whitehead Patents covering iPSC technology.
- Fate strongly disagrees with ruling and will consider appeal; validity and enforceability of patents unaffected.
- State case for breach of contract and fraud against Shoreline ongoing; trial set for January 2024.
- Shoreline argued it purchases iPSC lines from third parties, not directly infringing Fate's patents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434316/000119312523227749/0001193125-23-227749-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434316/000119312523227749/d549067d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-227749

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer